{"id":"W4417069316","doi":"10.1182/blood-2025-7300","title":"Real-world data comparison of asciminib 40 mg twice daily vs. 80 mg once daily in chronic myeloid leukemia patients","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Discontinuation; Myeloid leukemia; Adverse effect; Tyrosine-kinase inhibitor; Survival analysis; Leukemia; Nilotinib; Myeloid; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003103732,0.0003808135,0.0007506325,0.0003356113,0.000230634,0.0008083223,0.0003412212,0.0006219095,0.003066517],"category_scores_gemma":[0.004921567,0.0001682912,0.0008421707,0.0005837292,0.0004038764,0.0006114729,0.0003327356,0.0006470475,0.0004027137],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008115998,"about_ca_system_score_gemma":0.0003779448,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004519303,"about_ca_topic_score_gemma":0.0003654909,"domain_scores_codex":[0.998051,0.001059446,0.0002086031,0.0003446295,0.0002401801,0.00009608216],"domain_scores_gemma":[0.9951821,0.001832211,0.001973466,0.0002832961,0.000325081,0.0004038663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6018755,0.0058186,0.2890101,0.001384355,0.004261435,0.0004150992,0.000313781,0.005722716,0.01020842,0.0004451938,0.003251701,0.07729296],"study_design_scores_gemma":[0.05295603,0.2941569,0.6205475,0.0002037632,0.003523582,0.001450533,0.000357172,0.008450848,0.006536764,0.000407211,0.01129278,0.0001168822],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956132,0.001669906,0.0002202217,0.00007851027,0.00001774506,0.0001529077,0.001277411,0.00001182606,0.0009582276],"genre_scores_gemma":[0.9977944,0.0002598771,0.0001787276,0.00009020761,0.00003029572,0.0001228438,0.00134392,0.000002711145,0.0001769448],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003103732,"threshold_uncertainty_score":0.01641428,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03434395425559256,"score_gpt":0.3315944448529916,"score_spread":0.2972504905973991,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}